BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 4884961)

  • 1. Further studies with artificial antigens and immunity to mouse typhoid. I. Use of O acetylated galactans in the purification of specific antibody against antigen 5.
    Jackson GD; Rowley D; Jenkin CR
    Immunology; 1968 Dec; 15(6):789-98. PubMed ID: 4884961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation of an artificial antigen and immunity to mouse typhoid.
    Jenkin CR; Karnovsky ML; Rowley D
    Immunology; 1967 Oct; 13(4):361-72. PubMed ID: 4861746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Artificial antigens and immunity to infectious disease.
    Jenkin CR; Jackson GD
    Prog Immunobiol Stand; 1970; 4():493-504. PubMed ID: 5482193
    [No Abstract]   [Full Text] [Related]  

  • 4. Antigenic determinants of Salmonella for production of "clearance" factor in mouse typhoid.
    Nakano M; Saito K; Toyasaki N
    Jpn J Microbiol; 1970 Mar; 14(2):163-70. PubMed ID: 4910537
    [No Abstract]   [Full Text] [Related]  

  • 5. Further studies on artificial antigens and immunity to mouse typhoid. II. The ability of galactans containing various acyl groups to immunise mice against mouse typhoid.
    Jackson GD; Jenkin CR
    Aust J Exp Biol Med Sci; 1969 Feb; 47(1):91-6. PubMed ID: 4890820
    [No Abstract]   [Full Text] [Related]  

  • 6. Further studies regarding the question of cellular immunity in mouse typhoid.
    Rowley D; Auzins I; Jenkin CR
    Aust J Exp Biol Med Sci; 1968 Aug; 46(4):447-63. PubMed ID: 4879050
    [No Abstract]   [Full Text] [Related]  

  • 7. Monoclonal antibodies to Salmonella lipopolysaccharide: anti-O-polysaccharide antibodies protect C3H mice against challenge with virulent Salmonella typhimurium.
    Colwell DE; Michalek SM; Briles DE; Jirillo E; McGhee JR
    J Immunol; 1984 Aug; 133(2):950-7. PubMed ID: 6203984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of enteral immunization against typhoid fever with chemical Vi and O antigens.
    Pershin BB
    Fed Proc Transl Suppl; 1965; 24(6):1079-80. PubMed ID: 5321225
    [No Abstract]   [Full Text] [Related]  

  • 9. Problems of anti-typhoid immunity and protective vaccination against typhoid.
    Karolcek J
    Lek Pr; 1969; 7(1):3-153. PubMed ID: 4917329
    [No Abstract]   [Full Text] [Related]  

  • 10. Specific and cross-reactive immune response to oral Salmonella Typhi Ty21a and parenteral Vi capsular polysaccharide typhoid vaccines administered concomitantly.
    Pakkanen SH; Kantele JM; Savolainen LE; Rombo L; Kantele A
    Vaccine; 2015 Jan; 33(3):451-8. PubMed ID: 25433216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neutralization reaction of bacteriolysins and its application for the titration of salmonella O antigens.
    Tendetnik YY; Levi MI; Rukhadze EZ; Vydrina EI; Pryamukhina NS
    J Hyg Epidemiol Microbiol Immunol; 1973; 17(1):104-13. PubMed ID: 4575461
    [No Abstract]   [Full Text] [Related]  

  • 12. Low sensitivity of counter-current immuno-electrophoresis for serodiagnosis of typhoid fever.
    Sharma M; Datta U; Roy P; Verma S; Sehgal S
    J Med Microbiol; 1997 Dec; 46(12):1039-42. PubMed ID: 9402926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cross-reactive immune response elicited by parenteral Vi polysaccharide typhoid vaccine against non-typhoid Salmonellae.
    Pakkanen SH; Kantele JM; Herzog C; Kantele A
    Vaccine; 2014 Jan; 32(5):544-51. PubMed ID: 24342246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective roles of mucosal and serum immunity against typhoid fever.
    Robbins JB; Schneerson R; Acharya IL; Lowe CU; Szu SS; Daniels E; Yang YH; Trollfors B
    Monogr Allergy; 1988; 24():315-20. PubMed ID: 3362148
    [No Abstract]   [Full Text] [Related]  

  • 15. [Cross-reacting antigens of Opisthorchis felineus and Salmonella typhi and their possible effect on the clinical course of typhoid fever].
    Lepekhin AV; Ratner GM; Meniavtseva TA
    Med Parazitol (Mosk); 1990; (4):33-6. PubMed ID: 2233535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [An immunoblotting as a method for the diagnosis of typhoid fever].
    Dera-Tomaszewska B; Głośnicka R
    Med Dosw Mikrobiol; 2007; 59(3):241-50. PubMed ID: 18078119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Live oral typhoid vaccine Salmonella Typhi Ty21a - a surrogate vaccine against non-typhoid salmonella?
    Kantele A; Pakkanen SH; Siitonen A; Karttunen R; Kantele JM
    Vaccine; 2012 Nov; 30(50):7238-45. PubMed ID: 23084770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetically modified Bifidobacterium displaying Salmonella-antigen protects mice from lethal challenge of Salmonella Typhimurium in a murine typhoid fever model.
    Yamamoto S; Wada J; Katayama T; Jikimoto T; Nakamura M; Kinoshita S; Lee KM; Kawabata M; Shirakawa T
    Vaccine; 2010 Sep; 28(41):6684-91. PubMed ID: 20709009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Typhoid carriers. I. Immunoelectrophoretic study of antibodies in the sera of carriers and patients with typhoid fever.
    Ciznár I; Odler I; Mikulková V
    J Hyg Epidemiol Microbiol Immunol; 1967; 11(4):433-8. PubMed ID: 5629907
    [No Abstract]   [Full Text] [Related]  

  • 20. Protection against mouse typhoid by artificial Salmonella vaccines.
    Svenson SB; Lindberg AA
    Scand J Infect Dis Suppl; 1980; Suppl 24():210-5. PubMed ID: 6163199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.